财务摘要（报告期）（Biohaven Pharmaceutical Holding Co Ltd）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 每股指标： | ||||||||
| 每股收益EPS基本(元) | -5.73 | -3.86 | -2.36 | -1.03 | -12.75 | -9.38 | - | -2.46 |
| 每股净资产(元) | 5.28 | 4.24 | 5.67 | 6.92 | 7.90 | - | - | - |
| 每股经营现金净流量(元) | -4.09 | -3.17 | -1.79 | -1.14 | -4.37 | - | - | - |
| 每股现金流量净额(元) | 0.12 | -1.71 | -0.60 | -0.76 | 2.43 | - | - | - |
| 盈利能力： | ||||||||
| 净资产收益率平均(%) | -84.44 | -63.57 | -34.74 | -13.94 | -198.89 | -547.30 | -1,006.28 | - |
| 总资产净利率(%) | -69.48 | -50.44 | -27.53 | -11.01 | -141.89 | -265.87 | -249.97 | - |
| 投入资本回报率ROIC(%) | -113.11 | -72.37 | -39.42 | -14.83 | -246.39 | -811.53 | -741.39 | - |
| 收益质量： | ||||||||
| 营业利润／利润总额(%) | 106.47 | 107.12 | 108.92 | 111.83 | 99.66 | 99.98 | 99.98 | 100.00 |
| 资本结构： | ||||||||
| 资产负债率(%) | 16.61 | 24.23 | 23.58 | 23.65 | 18.59 | 26.12 | 74.55 | - |
| 权益乘数 | 1.20 | 1.32 | 1.31 | 1.31 | 1.23 | 1.35 | 3.93 | 1.00 |
| 产权比率 | 0.20 | 0.32 | 0.31 | 0.31 | 0.23 | 0.35 | 2.93 | - |
| 流动资产／总资产(%) | 86.21 | 81.14 | 85.67 | 88.03 | 88.69 | 59.38 | 47.60 | - |
| 非流动资产／总资产(%) | 13.79 | 18.86 | 14.33 | 11.97 | 11.31 | 40.62 | 52.40 | - |
| 流动负债／负债合计(%) | 65.02 | 67.05 | 73.52 | 77.95 | 73.18 | 80.26 | 89.93 | - |
| 非流动负债／负债合计(%) | 34.98 | 32.95 | 26.48 | 22.05 | 26.82 | 19.74 | 10.07 | - |
| 归属母公司股东的权益／投入资本(%) | 161.62 | 107.00 | 107.83 | 95.70 | 117.92 | 117.93 | 33.33 | - |
| 偿债能力： | ||||||||
| 流动比率 | 7.98 | 4.99 | 4.94 | 4.78 | 6.52 | 2.83 | 0.71 | - |
| 速动比率 | 7.98 | 4.99 | 4.94 | 4.78 | 6.52 | 2.83 | 0.71 | - |
| 货币资金／流动负债(%) | 448.19 | 179.64 | 168.03 | 109.67 | 227.59 | 178.19 | 35.25 | - |
| 营业利润／流动负债(%) | -786.77 | -454.09 | -195.56 | -68.23 | -630.89 | -1,246.77 | -435.66 | - |
| 经营活动产生的现金流量净额／流动负债(%) | -598.53 | -348.75 | -138.91 | -68.10 | -330.69 | -781.72 | -192.44 | - |
| 归属母公司股东的权益／负债合计(%) | 502.10 | 312.74 | 324.11 | 322.88 | 437.98 | 282.86 | 34.14 | - |
| 经营活动产生的现金流量净额／负债合计(%) | -389.18 | -233.84 | -102.13 | -53.08 | -242.00 | -627.38 | -173.07 | - |
| 营业利润／负债合计(%) | -511.57 | -304.48 | -143.78 | -53.18 | -461.69 | -1,000.62 | -391.80 | - |
| 成长能力： | ||||||||
| 总资产同比增长率(%) | -22.45 | 182.16 | 415.92 | - | 365.84 | - | - | - |
| 每股净资产同比增长率(%) | -33.22 | - | - | - | - | - | - | - |
| 总负债同比增长率(%) | -30.71 | 161.73 | 63.18 | - | 159.68 | - | - | - |
| 基本每股收益同比增长率(%) | 55.06 | 58.85 | 69.07 | 58.13 | -134.81 | -128.22 | - | - |
| 归属母公司股东的权益同比增长率(%) | -20.56 | 189.38 | 1,449.14 | - | 1,453.06 | - | - | - |
| 营业利润同比增长率(%) | 23.22 | 20.36 | 40.12 | 13.36 | -159.45 | -111.00 | -154.95 | - |
| 股东权益合计同比增长率(%) | -20.56 | 189.38 | 1,449.14 | - | 468.98 | - | - | - |
| 营运能力： | ||||||||
| 衍生指标： | ||||||||
| 现金及现金等价物净增加额TTM(元) | 9,516,000.00 | 74,572,000.00 | 177,991,000.00 | 149,582,000.00 | 165,547,000.00 | -311,281,000.00 | -67,461,000.00 | -6,449,000.00 |
| 利润总额TTM(元) | -409,551,000.00 | -478,833,000.00 | -440,609,000.00 | -549,617,000.00 | -569,841,000.00 | -404,020,000.00 | -391,880,000.00 | -212,430,000.00 |
| 投入资本(元) | 264,810,000.00 | 271,039,000.00 | 359,124,000.00 | 493,490,000.00 | 456,906,000.00 | 84,978,000.00 | 75,011,000.00 | - |
| 经营活动产生的现金流量净额TTM(元) | -331,725,000.00 | -292,251,000.00 | -292,998,000.00 | -316,491,000.00 | -297,689,000.00 | -255,338,000.00 | -203,509,000.00 | -145,840,000.00 |
| 归属母公司净利润TTM(元) | -408,168,000.00 | -464,519,000.00 | -430,798,000.00 | -543,739,000.00 | -570,279,000.00 | -421,058,000.00 | -406,570,000.00 | -213,796,000.00 |
| 所得税TTM(元) | -1,383,000.00 | -14,314,000.00 | -9,811,000.00 | -5,878,000.00 | 438,000.00 | 17,038,000.00 | 14,690,000.00 | 1,366,000.00 |